Earnings on Tap: Heavyweights to Report Tuesday Morning
Wall Street sees profit increases for Goldman, Wells Fargo, J&J, and Coke, while Bank of America could lose ground.
Wall Street sees profit increases for Goldman, Wells Fargo, J&J, and Coke, while Bank of America could lose ground.
The Goldman Sachs Group (GS) is scheduled to report second-quarter results before the bell Tuesday. Wall Street analysts expect earnings of $2.35 per share. In the year-ago quarter the company reported earnings of $0.78.
The global financial turmoil, the Greek bond crisis, and weak trading revenue in the bonds, commodities, and currency markets will likely affect Goldman Sachs' earnings, similar to what has happened with its peers. However, investment banking revenue will likely show good growth, also in line with those reported by peers earlier.
Investors will want clarity on media reports of more than 200 job cuts that might be in the offing and a plan to reduce noncompensation expense by as much as $1 billion.
Bank of America (BAC) is also slated to declare earnings before the bell Tuesday. Analysts, on average, expect the firm to post a profit of $0.09 per share, compared with $0.27 per share in prior-year quarter.
Bank of America said June 29 it would take a $8.5 billion hit over settlement-related mortgage-backed securities charges.
Even as analysts would hope the deal signals the end of the bank's settlement troubles and clears uncertainty relating to future charges, they will look to see how management intends to build its capital base to meet international capital-requirement norms that will be implemented in the near future.
Wells Fargo (WFC) is a third financial-services firm reporting Tuesday morning, with a survey of analysts expecting the firm to clock earnings per share of $0.69, compared with $0.55 in the same quarter last year.
Wells Fargo shares are highly undervalued at current prices, according to Morningstar analyst Jaime Peters, who believes the bank's net charge-offs have peaked and will start to trend downward.
Outside of the financial-services industry, Johnson & Johnson (JNJ) is expected to post earnings of $1.24 per share, slightly up from $1.23 in the year-ago quarter.
With the health-care major's spate of product recalls, which troubled the firm in 2010 and early 2011, coming to a visible end, investors can focus on management's strategy to roll out products in the wake of key patent losses in the past few years. Morningstar analyst Damien Conover thinks Johnson & Johnson shares have been trading at a discount.
Investors will also focus on Coca-Cola's (KO) earnings report before the opening bell Tuesday. Wall Street analysts expect earnings of $1.15 per share against $1.02 a year earlier. Revenue is expected to get a boost owing to the recent acquisition of Coca Cola Enterprises' North American operations.
The Street will look for Coke's growth in emerging markets such as Asia, Latin America, and Eastern Europe in the face of declining consumption of carbonated beverages in the firm's key North American market. Morningstar analyst Philip Gorham believes the Coke's global reach will hold the firm in good stead to meet these challenges and that Coke's investments in Asia and Eastern Europe will be a key valuation driver in the medium term.
Rouhan Sharma contributed to this article.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.